| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| TECHBio-Techne Corporation | 10.9B | 69.96 | 152.09 | 5.23% | 6.41% | 3.97% | 2.35% | 0.23 |
| SPRYARS Pharmaceuticals, Inc. | 1.1B | 11.09 | 142.00 | 2970.63% | -56.06% | -54.21% | 1.18% | 0.00 |
| VCYTVeracyte, Inc. | 3.24B | 41.00 | 132.26 | 23.46% | 6.12% | 2.41% | 1.97% | 0.04 |
| CSBRChampions Oncology, Inc. | 99.56M | 7.17 | 21.73 | 13.54% | 4.32% | 59.65% | 7.03% | 1.62 |
| MDXGMiMedx Group, Inc. | 851.59M | 5.75 | 20.54 | 8.52% | 10.38% | 17.09% | 7.58% | 0.13 |
| LTRNLantern Pharma Inc. | 39.26M | 3.51 | -0.00 | -197.36% | 0.01 | |||
| SEERSeer, Inc. | 107.44M | 1.91 | -1.37 | -8.13% | -486.02% | -29.19% | 0.08 | |
| IMDXInsight Molecular Diagnostics Inc. | 189.76M | 6.62 | -1.42 | 25.15% | -13.81% | -14.81% |
| Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 42.55M | 2.41M | 17.34M | 16.72M | 32.16M | 7.46M | 10.21M | 7.5M | 5.9M | 17.2M |
| Revenue Growth % | 0.79% | -0.94% | 6.19% | -0.04% | 0.92% | -0.77% | 0.37% | -0.27% | -0.21% | 1.91% |
| Cost of Goods Sold | 29.76M | 12.06M | 5.51M | 75.17M | 81.5M | 85.73M | 63.57M | 54.92M | 41.07M | 5.13M |
| COGS % of Revenue | 0.7% | 5% | 0.32% | 4.5% | 2.53% | 11.5% | 6.23% | 7.32% | 6.96% | 0.3% |
| Gross Profit | 12.79M | -9.65M | 11.83M | -58.45M | -49.34M | -78.28M | -53.36M | -47.42M | -35.17M | 12.07M |
| Gross Margin % | 0.3% | -4% | 0.68% | -3.5% | -1.53% | -10.5% | -5.23% | -6.32% | -5.96% | 0.7% |
| Gross Profit Growth % | 366.29% | -1.76% | 2.23% | -5.94% | 0.16% | -0.59% | 0.32% | 0.11% | 0.26% | 1.34% |
| Operating Expenses | 98.44M | 92.5M | 92.03M | 97.88M | 107.56M | 115.06M | 90.78M | 76.79M | 48.98M | 74.51M |
| OpEx % of Revenue | 2.31% | 38.35% | 5.31% | 5.85% | 3.34% | 15.43% | 8.89% | 10.24% | 8.3% | 4.33% |
| Selling, General & Admin | 52.26M | 35.07M | 27.41M | 36.98M | 50.92M | 63.59M | 57.97M | 53.11M | 23.63M | 39.31M |
| SG&A % of Revenue | 1.23% | 14.54% | 1.58% | 2.21% | 1.58% | 8.53% | 5.68% | 7.08% | 4% | 2.29% |
| Research & Development | 50.01M | 58.91M | 65.93M | 59.81M | 56.19M | 53.01M | 32.81M | 27.19M | 25.35M | 34.81M |
| R&D % of Revenue | 1.18% | 24.43% | 3.8% | 3.58% | 1.75% | 7.11% | 3.21% | 3.62% | 4.3% | 2.02% |
| Other Operating Expenses | 25.92M | 10.53M | -1.31M | 15.48M | 25.23M | 32.65M | 30.76M | 0 | 0 | 395K |
| Operating Income | -55.89M | -90.04M | -77.34M | -80.2M | -74.87M | -109.1M | -80.57M | -69.29M | -84.15M | -62.44M |
| Operating Margin % | -1.31% | -37.33% | -4.46% | -4.8% | -2.33% | -14.63% | -7.89% | -9.24% | -14.26% | -3.63% |
| Operating Income Growth % | 0.51% | -0.61% | 0.14% | -0.04% | 0.07% | -0.46% | 0.26% | 0.14% | -0.21% | 0.26% |
| EBITDA | -53.7M | -86.98M | -74.69M | -78.06M | -71.2M | -104.83M | -76.19M | -65.18M | -82.25M | -56.04M |
| EBITDA Margin % | -1.26% | -36.06% | -4.31% | -4.67% | -2.21% | -14.06% | -7.46% | -8.69% | -13.94% | -3.26% |
| EBITDA Growth % | 0.52% | -0.62% | 0.14% | -0.05% | 0.09% | -0.47% | 0.27% | 0.14% | -0.26% | 0.32% |
| D&A (Non-Cash Add-back) | 2.19M | 3.06M | 2.65M | 2.14M | 3.67M | 4.26M | 4.38M | 4.11M | 1.9M | 6.4M |
| EBIT | -90.82M | -90.22M | -64.15M | -86.67M | -72.64M | -88.92M | -74.3M | -62.66M | -57.97M | -80.06M |
| Net Interest Income | 1.08M | 468K | -1.46M | -10.98M | -14.17M | -10.71M | -17.29M | -18.61M | -18.83M | -19.38M |
| Interest Income | 1.08M | 468K | 366K | 719K | 542K | 0 | 0 | 831K | 1.82M | 3.55M |
| Interest Expense | 0 | 0 | 1.83M | 11.7M | 14.72M | 10.71M | 17.29M | 19.44M | 20.66M | 22.93M |
| Other Income/Expense | -34.93M | -173K | 9.24M | -18.34M | -12.48M | 9.47M | -10.48M | -12.81M | -4M | -39.37M |
| Pretax Income | -90.82M | -90.22M | -65.98M | -98.75M | -87.36M | -99.63M | -91.59M | -82.1M | -88.15M | -101.81M |
| Pretax Margin % | -2.13% | -37.4% | -3.8% | -5.91% | -2.72% | -13.36% | -8.97% | -10.95% | -14.94% | -5.92% |
| Income Tax | -86.69M | -13.4M | -30.69M | -8.96M | -9.41M | -819K | -239K | -212K | -191K | 330K |
| Effective Tax Rate % | 0.05% | 0.85% | 0.53% | 0.91% | 0.89% | 0.99% | 1% | 1% | 1% | 1% |
| Net Income | -4.13M | -76.81M | -35.29M | -89.8M | -77.94M | -98.81M | -91.35M | -81.89M | -87.96M | -102.14M |
| Net Margin % | -0.1% | -31.85% | -2.04% | -5.37% | -2.42% | -13.25% | -8.95% | -10.92% | -14.9% | -5.94% |
| Net Income Growth % | 0.97% | -17.61% | 0.54% | -1.54% | 0.13% | -0.27% | 0.08% | 0.1% | -0.07% | -0.16% |
| Net Income (Continuing) | -4.13M | -76.81M | -35.29M | -89.8M | -77.94M | -98.81M | -91.35M | -81.89M | -87.96M | -102.14M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.08 | -1.40 | -0.76 | -1.80 | -1.50 | -1.60 | -1.30 | -0.98 | -0.89 | -0.84 |
| EPS Growth % | 0.96% | -17.18% | 0.46% | -1.37% | 0.17% | -0.07% | 0.19% | 0.25% | 0.09% | 0.06% |
| EPS (Basic) | -0.08 | -1.40 | -0.76 | -1.80 | -1.50 | -1.60 | -1.30 | -0.98 | -0.89 | -0.84 |
| Diluted Shares Outstanding | 53.77M | 53.77M | 46.57M | 49.44M | 52.88M | 60.51M | 68.29M | 83.93M | 98.67M | 120.78M |
| Basic Shares Outstanding | 53.77M | 53.77M | 46.56M | 49.44M | 52.88M | 60.51M | 68.27M | 83.77M | 98.67M | 120.78M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
| Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 88.82M | 63.61M | 101.07M | 62.52M | 136.55M | 148.23M | 69.84M | 81.66M | 86.46M | 204.35M |
| Cash & Short-Term Investments | 21.86M | 45.76M | 37.76M | 50.43M | 129.33M | 136.88M | 60.03M | 70.92M | 62.56M | 161.16M |
| Cash Only | 21.86M | 45.76M | 37.76M | 50.43M | 129.33M | 136.88M | 60.03M | 70.92M | 62.56M | 161.16M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 715K | 1.29M | 46.28M | 1.74M | 1.32M | 4.59M | 4.4M | 7M | 20.95M | 14.87M |
| Days Sales Outstanding | 6.13 | 195.51 | 974.03 | 38 | 15.01 | 224.7 | 157.39 | 340.52 | 1.3K | 315.51 |
| Inventory | 59.08M | 13.86M | -43.74M | -250K | -252K | -252K | 0 | 0 | 0 | 22.25M |
| Days Inventory Outstanding | 724.49 | 419.15 | - | - | - | - | - | - | - | 1.58K |
| Other Current Assets | 59.08M | 38.04M | 542K | 421K | 412K | 451K | 413K | 398K | 397K | 393K |
| Total Non-Current Assets | 595.2M | 592.08M | 591.37M | 589.59M | 597.05M | 596.49M | 592.3M | 587.76M | 582.69M | 580.33M |
| Property, Plant & Equipment | 3.06M | 1.81M | 1.08M | 826K | 10.27M | 12.14M | 9.96M | 6.49M | 3.84M | 5.82M |
| Fixed Asset Turnover | 13.89x | 1.33x | 16.00x | 20.24x | 3.13x | 0.61x | 1.02x | 1.16x | 1.54x | 2.95x |
| Goodwill | 134.45M | 134.45M | 134.45M | 134.45M | 134.45M | 134.45M | 134.45M | 134.45M | 134.45M | 134.45M |
| Intangible Assets | 453.37M | 451.9M | 450.15M | 448.67M | 447.15M | 446.09M | 444.2M | 442.73M | 441.28M | 437.37M |
| Long-Term Investments | 1.97M | 2M | 2.32M | 2.32M | 1.87M | 2.08M | 1.76M | 1.76M | 1.01M | 1.39M |
| Other Non-Current Assets | 2.34M | 1.92M | 3.36M | 3.32M | 3.31M | 1.72M | 1.68M | 481K | 2.1M | 1.3M |
| Total Assets | 684.02M | 655.69M | 692.44M | 652.12M | 733.6M | 744.72M | 662.14M | 669.41M | 669.15M | 784.68M |
| Asset Turnover | 0.06x | 0.00x | 0.03x | 0.03x | 0.04x | 0.01x | 0.02x | 0.01x | 0.01x | 0.02x |
| Asset Growth % | -0.33% | -0.04% | 0.06% | -0.06% | 0.12% | 0.02% | -0.11% | 0.01% | -0% | 0.17% |
| Total Current Liabilities | 29.41M | 36.67M | 24M | 44.33M | 90.14M | 94.27M | 51.37M | 41.98M | 73.24M | 102.63M |
| Accounts Payable | 27.16M | 21.8M | 18.92M | 13.06M | 24.97M | 19.6M | 23.08M | 20.14M | 7.07M | 19.08M |
| Days Payables Outstanding | 333.02 | 659.66 | 1.25K | 63.41 | 111.84 | 83.44 | 132.51 | 133.88 | 62.83 | 1.36K |
| Short-Term Debt | 0 | 0 | 0 | 14.01M | 32.45M | 53.2M | 5.02M | 5.95M | 13.86M | 54.16M |
| Deferred Revenue (Current) | 0 | 0 | 0 | -1000K | -1000K | -1000K | 1000K | 1000K | 0 | 0 |
| Other Current Liabilities | 2.26M | 14.87M | 5.08M | 17.26M | 29.2M | 18.71M | 2.19M | 5.43M | 49.69M | 26.71M |
| Current Ratio | 3.02x | 1.73x | 4.21x | 1.41x | 1.51x | 1.57x | 1.36x | 1.95x | 1.18x | 1.99x |
| Quick Ratio | 1.01x | 1.36x | 6.03x | 1.42x | 1.52x | 1.57x | 1.36x | 1.95x | 1.18x | 1.77x |
| Cash Conversion Cycle | 397.61 | -45 | - | - | - | - | - | - | - | 540.63 |
| Total Non-Current Liabilities | 126.44M | 102.25M | 122.43M | 126.73M | 94.13M | 69.05M | 113.72M | 125.59M | 115.56M | 84.61M |
| Long-Term Debt | 0 | 0 | 59.4M | 67.28M | 57.02M | 41.05M | 91.62M | 102.81M | 100.48M | 67.74M |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 6.32M | 8.48M | 7.08M | 3.67M | 1.95M | 3.58M |
| Deferred Tax Liabilities | 62.69M | 49.29M | 20.08M | 11.12M | 730K | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 63.75M | 52.96M | 63.03M | 59.45M | 30.79M | 19.52M | 15.02M | 19.11M | 13.12M | 13.29M |
| Total Liabilities | 155.86M | 138.92M | 146.44M | 171.06M | 184.28M | 163.32M | 165.1M | 167.58M | 188.8M | 187.24M |
| Total Debt | 0 | 0 | 59.4M | 81.29M | 99.31M | 105.5M | 106.91M | 116.5M | 118.92M | 128.16M |
| Net Debt | -21.86M | -45.76M | 21.63M | 30.86M | -30.01M | -31.39M | 46.87M | 45.58M | 56.36M | -33M |
| Debt / Equity | - | - | 0.11x | 0.17x | 0.18x | 0.18x | 0.22x | 0.23x | 0.25x | 0.21x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | -42.28x | -6.85x | -5.09x | -10.18x | -4.66x | -3.56x | -4.07x | -2.72x |
| Total Equity | 528.16M | 516.77M | 546.01M | 481.05M | 549.33M | 581.4M | 497.04M | 501.84M | 480.36M | 597.44M |
| Equity Growth % | -0.13% | -0.02% | 0.06% | -0.12% | 0.14% | 0.06% | -0.15% | 0.01% | -0.04% | 0.24% |
| Book Value per Share | 9.82 | 9.61 | 11.72 | 9.73 | 10.39 | 9.61 | 7.28 | 5.98 | 4.87 | 4.95 |
| Total Shareholders' Equity | 528.16M | 516.77M | 546.01M | 481.05M | 549.33M | 581.4M | 497.04M | 501.84M | 480.36M | 597.44M |
| Common Stock | 770.27M | 830.42M | 889.48M | 910.4M | 1.05B | 1.16B | 1.17B | 1.25B | 1.31B | 1.51B |
| Retained Earnings | -268.09M | -344.9M | -380.19M | -469.99M | -548.76M | -647.57M | -738.92M | -820.8M | -908.76M | -1.01B |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 25.98M | 31.24M | 36.72M | 40.64M | 46.63M | 65.81M | 70.65M | 73.52M | 78.3M | 99.5M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -88M | -95.47M | -75.01M | -57.79M | -56.37M | -106.68M | -65.78M | -63.27M | -48.46M | -49.95M |
| Operating CF Margin % | -2.07% | -39.58% | -4.33% | -3.46% | -1.75% | -14.31% | -6.44% | -8.43% | -8.21% | -2.9% |
| Operating CF Growth % | 0.28% | -0.08% | 0.21% | 0.23% | 0.02% | -0.89% | 0.38% | 0.04% | 0.23% | -0.03% |
| Net Income | -4.13M | -76.81M | -35.29M | -89.8M | -77.94M | -98.81M | -91.35M | -81.89M | -87.96M | -102.14M |
| Depreciation & Amortization | 2.19M | 3.06M | 2.65M | 2.14M | 3.67M | 4.26M | 4.38M | 4.11M | 4.67M | 6.4M |
| Stock-Based Compensation | 3.39M | 5.28M | 6.2M | 4.37M | 7.52M | 12.51M | 5.54M | 3.65M | 5.87M | 22.09M |
| Deferred Taxes | -86.69M | -13.4M | -30.66M | -8.96M | -9.41M | -819K | -235K | -212K | -191K | 330K |
| Other Non-Cash Items | -2.61M | 168K | -8.98M | 14.02M | 6.51M | -15.41M | 11.02M | 13.54M | 31.78M | 26.41M |
| Working Capital Changes | -144K | -13.76M | -8.93M | 20.44M | 13.29M | -8.42M | 4.87M | -2.47M | -2.63M | -3.04M |
| Change in Receivables | -531K | -859K | -6.09M | 4.97M | 890K | -1.74M | 140K | -118K | -15.47M | 6.29M |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 826K |
| Change in Payables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Investing | -1.73M | 142K | -1.15M | -1M | -3.27M | -1.65M | -232K | -194K | -97K | 120K |
| Capital Expenditures | -922K | -311K | -201K | -279K | -2.25M | -1.65M | -232K | -314K | -271K | -680K |
| CapEx % of Revenue | 0.02% | 0.13% | 0.01% | 0.02% | 0.07% | 0.22% | 0.02% | 0.04% | 0.05% | 0.04% |
| Acquisitions | - | - | - | - | - | - | - | - | - | - |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -1M | 453K | -952K | -721K | -1.03M | 0 | -75K | 120K | -60K | 559K |
| Cash from Financing | 62.07M | 60.01M | 68.61M | 71.61M | 137.04M | 114.47M | -9.87M | 74.5M | 40.25M | 147.34M |
| Debt Issued (Net) | - | - | - | - | - | - | - | - | - | - |
| Equity Issued (Net) | - | - | - | - | - | - | - | - | - | - |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | - | - | - | - | - | - | - | - | - | - |
| Other Financing | -6.48M | -1.93M | -3.66M | -2.22M | -6.28M | 5.2M | -3.75M | -11.48M | -11.63M | -4.1M |
| Net Change in Cash | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | -88.92M | -95.78M | -75.21M | -58.07M | -58.61M | -108.33M | -66.01M | -63.58M | -48.79M | -50.68M |
| FCF Margin % | -2.09% | -39.71% | -4.34% | -3.47% | -1.82% | -14.53% | -6.46% | -8.48% | -8.27% | -2.95% |
| FCF Growth % | 0.29% | -0.08% | 0.21% | 0.23% | -0.01% | -0.85% | 0.39% | 0.04% | 0.23% | -0.04% |
| FCF per Share | -1.65 | -1.78 | -1.62 | -1.17 | -1.11 | -1.79 | -0.97 | -0.76 | -0.49 | -0.42 |
| FCF Conversion (FCF/Net Income) | 21.32x | 1.24x | 2.13x | 0.64x | 0.72x | 1.08x | 0.72x | 0.77x | 0.55x | 0.49x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -0.73% | -14.7% | -6.64% | -17.49% | -15.13% | -17.48% | -16.94% | -16.4% | -17.91% | -18.95% |
| Return on Invested Capital (ROIC) | -7.7% | -13.82% | -11.17% | -11.14% | -10.89% | -15.3% | -11.05% | -9.52% | -11.64% | -8.51% |
| Gross Margin | 30.05% | -400.21% | 68.24% | -349.55% | -153.44% | -1049.83% | -522.58% | -632.2% | -595.87% | 70.17% |
| Net Margin | -9.7% | -3184.7% | -203.51% | -537.01% | -242.38% | -1325.25% | -894.59% | -1091.71% | -1490.27% | -593.92% |
| Debt / Equity | - | - | 0.11x | 0.17x | 0.18x | 0.18x | 0.22x | 0.23x | 0.25x | 0.21x |
| Interest Coverage | - | - | -42.28x | -6.85x | -5.09x | -10.18x | -4.66x | -3.56x | -4.07x | -2.72x |
| FCF Conversion | 21.32x | 1.24x | 2.13x | 0.64x | 0.72x | 1.08x | 0.72x | 0.77x | 0.55x | 0.49x |
| Revenue Growth | 79.16% | -94.33% | 618.95% | -3.57% | 92.3% | -76.81% | 36.95% | -26.54% | -21.32% | 191.39% |
| 2020 | |
|---|---|
| AUSTRALIA | 20M |
| AUSTRALIA Growth | - |
Mesoblast Limited (MESO) reported $5.7M in revenue for fiscal year 2025. This represents a 85% decrease from $38.3M in 2012.
Mesoblast Limited (MESO) grew revenue by 191.4% over the past year. This is strong growth.
Mesoblast Limited (MESO) reported a net loss of $103.4M for fiscal year 2025.
Mesoblast Limited (MESO) has a return on equity (ROE) of -19.0%. Negative ROE indicates the company is unprofitable.
Mesoblast Limited (MESO) had negative free cash flow of $21.1M in fiscal year 2025, likely due to heavy capital investments.